- WhatsApp: +66 84 089 2692
- Official Distributor 71427321893
Partner, Prife International
Frequency and terahertz therapies are gaining recognition in numerous areas of medicine, and ophthalmology is no exception. Through technological innovations, such as those provided by IteraCare, eye treatments have benefited from the use of these therapies in their approach to sight recovery.
IteraCare has been at the forefront of developing terahertz devices to support recovery and health maintenance in a variety of areas, including ophthalmology. Terahertz technology, which operates with electromagnetic waves with wavelengths in the terahertz range (trillions of cycles per second), has unique properties for interaction with biological tissues, including ocular structures.
IteraCare devices, such as the iTera-Classic, iTera-Premium Plus, and iTera Pro, as well as the iTera-Bio Lite and iTera-Bio, can generate terahertz that can reach cells at deeper levels, stimulating natural regeneration and healing mechanisms.
The application of terahertz therapy in ophthalmology is relatively new, but there are already promising results. Terahertz radiation can interact with ocular tissues at molecular and cellular levels, with the potential to stimulate cell regeneration, which may be beneficial in the recovery of ocular degenerative diseases.
In addition, terahertz waves can help improve microcirculation in ocular tissues, promoting the delivery of nutrients and oxygen, essential elements for eye health and recovery.
The potential of terahertz therapies is enormous and, although we are still in the early stages of fully understanding their scope in ophthalmology, initial studies are encouraging. It is important to note that terahertz therapies should be used in combination with conventional ophthalmic treatments and protocols and always under medical supervision.
IteraCare continues to make significant advances in the development of terahertz devices and to play an active role in breaking new ground in ocular therapy. Meeting the challenges of eye disease and vision loss with cutting-edge innovations, IteraCare brings a valuable addition to treatment options to improve patients’ eye health and quality of life.
Terahertz therapy generates high frequency waves that can interact at the molecular and cellular level with the tissues of the eye. This interaction can stimulate cell regeneration and growth, improve microcirculation and promote natural healing, which is beneficial for recovery from various eye conditions.
While research is still ongoing, terahertz therapy could be beneficial in a variety of eye conditions, especially those involving cell damage or degeneration. This includes certain forms of macular degeneration, diabetic retinopathy, glaucoma, among others. However, a health care professional should always be consulted before initiating any new form of therapy.
The time required to see the effects of terahertz therapy may vary from patient to patient depending on the severity of the condition, the regularity of treatment and other individual factors. It is essential to maintain open communication with your healthcare professional and follow his or her recommendations to obtain the best possible results.
Meet Cool, the online conference room platform that revolutionizes the way we work and learn online. Maximize efficiency with real-time collaboration and interactive tools.”
